Log In
BCIQ
Print this Print this
 

SER-203

  Manage Alerts
Collapse Summary General Information
Company Serina Therapeutics Inc.
DescriptionPolyoxazoline with multiple molecules of anti-cancer drug irinotecan attached, with targeting group folate at the terminus
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentIND
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today